Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition

References

• Weigelt B, Peterse JL, van ’t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer 2005; 5:591 - 602; http://dx.doi.org/10.1038/nrc1670; PMID: 16056258
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177 - 82; http://dx.doi.org/10.1126/science.3798106; PMID: 3798106
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244:707 - 12; http://dx.doi.org/10.1126/science.2470152; PMID: 2470152
   PubMed Web of Science ®Google Scholar
• Eccles SA. The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis. J Mammary Gland Biol Neoplasia 2001; 6:393 - 406; http://dx.doi.org/10.1023/A:1014730829872; PMID: 12013529
   PubMed Web of Science ®Google Scholar
• Yarden Y. Biology of HER2 and its importance in breast cancer. Oncology 2001; 61:Suppl 2 1 - 13; http://dx.doi.org/10.1159/000055396; PMID: 11694782
   PubMed Web of Science ®Google Scholar
• Zhang S, Huang WC, Li P, Guo H, Poh SB, Brady SW, et al. Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat Med 2011; 17:461 - 9; http://dx.doi.org/10.1038/nm.2309; PMID: 21399647
   PubMed Web of Science ®Google Scholar
• Barker KT, Jackson LE, Crompton MR. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 1997; 15:799 - 805; http://dx.doi.org/10.1038/sj.onc.1201241; PMID: 9266966
   PubMed Web of Science ®Google Scholar
• Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res 2007; 67:4199 - 209; http://dx.doi.org/10.1158/0008-5472.CAN-06-3409; PMID: 17483331
   PubMed Web of Science ®Google Scholar
• Lee ST, Strunk KM, Spritz RA. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene 1993; 8:3403 - 10; PMID: 8247543
   PubMed Web of Science ®Google Scholar
• Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ, et al. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene 1994; 9:2383 - 90; PMID: 8036022
   PubMed Web of Science ®Google Scholar
• Siyanova EY, Serfas MS, Mazo IA, Tyner AL. Tyrosine kinase gene expression in the mouse small intestine. Oncogene 1994; 9:2053 - 7; PMID: 8208550
   PubMed Web of Science ®Google Scholar
• Qiu H, Miller WT. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition. J Biol Chem 2002; 277:34634 - 41; http://dx.doi.org/10.1074/jbc.M203877200; PMID: 12121988
   PubMed Web of Science ®Google Scholar
• Serfas MS, Tyner AL. Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol Res 2003; 13:409 - 19; PMID: 12725532
   PubMed Web of Science ®Google Scholar
• Harvey AJ, Crompton MR. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 2003; 22:5006 - 10; http://dx.doi.org/10.1038/sj.onc.1206577; PMID: 12902983
   PubMed Web of Science ®Google Scholar
• Harvey AJ, Crompton MR. The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges. Anticancer Drugs 2004; 15:107 - 11; http://dx.doi.org/10.1097/00001813-200402000-00002; PMID: 15075665
   PubMed Web of Science ®Google Scholar
• Haegebarth A, Heap D, Bie W, Derry JJ, Richard S, Tyner AL. The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. J Biol Chem 2004; 279:54398 - 404; http://dx.doi.org/10.1074/jbc.M409579200; PMID: 15471878
   PubMed Web of Science ®Google Scholar
• Derry JJ, Richard S, Valderrama Carvajal H, Ye X, Vasioukhin V, Cochrane AW, et al. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol Cell Biol 2000; 20:6114 - 26; http://dx.doi.org/10.1128/MCB.20.16.6114-6126.2000; PMID: 10913193
   PubMed Web of Science ®Google Scholar
• Lukong KE, Larocque D, Tyner AL, Richard S. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. J Biol Chem 2005; 280:38639 - 47; http://dx.doi.org/10.1074/jbc.M505802200; PMID: 16179349
   PubMed Web of Science ®Google Scholar
• Liu L, Gao Y, Qiu H, Miller WT, Poli V, Reich NC. Identification of STAT3 as a specific substrate of breast tumor kinase. Oncogene 2006; 25:4904 - 12; http://dx.doi.org/10.1038/sj.onc.1209501; PMID: 16568091
   PubMed Web of Science ®Google Scholar
• Weaver AM, Silva CM. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6. Breast Cancer Res 2007; 9:R79; http://dx.doi.org/10.1186/bcr1794; PMID: 17997837
   PubMed Web of Science ®Google Scholar
• Mitchell PJ, Sara EA, Crompton MR. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK. Oncogene 2000; 19:4273 - 82; http://dx.doi.org/10.1038/sj.onc.1203775; PMID: 10980601
   PubMed Web of Science ®Google Scholar
• Shen CH, Chen HY, Lin MS, Li FY, Chang CC, Kuo ML, et al. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion. Cancer Res 2008; 68:7779 - 87; http://dx.doi.org/10.1158/0008-5472.CAN-08-0997; PMID: 18829532
   PubMed Web of Science ®Google Scholar
• Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol 2004; 24:10558 - 72; http://dx.doi.org/10.1128/MCB.24.24.10558-10572.2004; PMID: 15572663
   PubMed Web of Science ®Google Scholar
• Vasioukhin V, Tyner AL. A role for the epithelial-cell-specific tyrosine kinase Sik during keratinocyte differentiation. Proc Natl Acad Sci U S A 1997; 94:14477 - 82; http://dx.doi.org/10.1073/pnas.94.26.14477; PMID: 9405638
   PubMed Web of Science ®Google Scholar
• Zhang P, Ostrander JH, Faivre EJ, Olsen A, Fitzsimmons D, Lange CA. Regulated association of protein kinase B/Akt with breast tumor kinase. J Biol Chem 2005; 280:1982 - 91; http://dx.doi.org/10.1074/jbc.M412038200; PMID: 15539407
   PubMed Web of Science ®Google Scholar
• Qiu H, Zappacosta F, Su W, Annan RS, Miller WT. Interaction between Brk kinase and insulin receptor substrate-4. Oncogene 2005; 24:5656 - 64; http://dx.doi.org/10.1038/sj.onc.1208721; PMID: 15870689
   PubMed Web of Science ®Google Scholar
• Li X, Lu Y, Liang K, Hsu JM, Albarracin C, Mills GB, et al. Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR. Oncogene 2012; 31:4372 - 83; http://dx.doi.org/10.1038/onc.2011.608; PMID: 22231447
   PubMed Web of Science ®Google Scholar
• Kamalati T, Jolin HE, Mitchell PJ, Barker KT, Jackson LE, Dean CJ, et al. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J Biol Chem 1996; 271:30956 - 63; http://dx.doi.org/10.1074/jbc.271.48.30956; PMID: 8940083
   PubMed Web of Science ®Google Scholar
• Kamalati T, Jolin HE, Fry MJ, Crompton MR. Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 2000; 19:5471 - 6; http://dx.doi.org/10.1038/sj.onc.1203931; PMID: 11114724
   PubMed Web of Science ®Google Scholar
• Born M, Quintanilla-Fend L, Braselmann H, Reich U, Richter M, Hutzler P, et al. Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J Pathol 2005; 205:592 - 6; http://dx.doi.org/10.1002/path.1720; PMID: 15685689
   PubMed Web of Science ®Google Scholar
• Xiang B, Chatti K, Qiu H, Lakshmi B, Krasnitz A, Hicks J, et al. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc Natl Acad Sci U S A 2008; 105:12463 - 8; http://dx.doi.org/10.1073/pnas.0805009105; PMID: 18719096
   PubMed Web of Science ®Google Scholar
• Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927 - 39; http://dx.doi.org/10.1016/j.cell.2004.06.006; PMID: 15210113
   PubMed Web of Science ®Google Scholar
• Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3:155 - 66; http://dx.doi.org/10.1038/nrm757; PMID: 11994736
   PubMed Web of Science ®Google Scholar
• Bromberg J. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Res 2000; 2:86 - 90; http://dx.doi.org/10.1186/bcr38; PMID: 11250696
   PubMed Web of Science ®Google Scholar
• Clevenger CV. Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 2004; 165:1449 - 60; http://dx.doi.org/10.1016/S0002-9440(10)63403-7; PMID: 15509516
   PubMed Web of Science ®Google Scholar
• Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002; 109:1139 - 42; PMID: 11994401
   PubMed Web of Science ®Google Scholar
• Gao SP, Bromberg JF. Touched and moved by STAT3. Sci STKE 2006; 2006:pe30; http://dx.doi.org/10.1126/stke.3432006pe30; PMID: 16835434
   PubMedGoogle Scholar
• Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131 - 42; http://dx.doi.org/10.1038/nrm1835; PMID: 16493418
   PubMed Web of Science ®Google Scholar
• Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172:973 - 81; http://dx.doi.org/10.1083/jcb.200601018; PMID: 16567498
   PubMed Web of Science ®Google Scholar
• Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, et al. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res 2007; 9:R32; http://dx.doi.org/10.1186/bcr1680; PMID: 17531096
   PubMed Web of Science ®Google Scholar
• Liang K, Lu Y, Jin W, Ang KK, Milas L, Fan Z. Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2003; 2:1113 - 20; PMID: 14617784
   PubMed Web of Science ®Google Scholar
• Liu B, Fang M, Schmidt M, Lu Y, Mendelsohn J, Fan Z. Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity. Br J Cancer 2000; 82:1991 - 9; PMID: 10864208
   PubMed Web of Science ®Google Scholar
• Li X, Luwor R, Lu Y, Liang K, Fan Z. Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells. Oncogene 2006; 25:525 - 35; PMID: 16170346
   PubMed Web of Science ®Google Scholar